Thorax
Clinical impact of customised positive airway pressure (PAP) therapy interfaces (3DPiPPIn): a single site randomised controlled trial.
Stephanie K Mansell, Swapna Mandal, Francesca Gowing, Deborah Ridout, Cherry Kilbride, Oliver Olsen, Stephen Hilton, Eleanor Main, Silvia Schievano
Published: 202610.1136/thorax-2025-224135
Abstract
INTRODUCTION: Positive airway pressure (PAP) therapy is the recognised treatment for sleep disordered breathing (SDB), delivered via a tight-fitting face mask (interface). Conventional interfaces do not consider facial geometries, often resulting in…
Preview only. Read the full abstract at the source